Italy
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 174.43 M
|
Dec. 31, 2023 | USD 22.41 | 2.19% |
|
Italy |
|
2 |
USD 82.01 M
|
Dec. 31, 2023 | USD 9.97 | 0.35% |
|
Italy |
|
3 |
USD 586.09
|
Dec. 31, 2023 | USD 3.52 | -12.00% |
|
Italy |
|
4 |
USD -211.92 K
|
Dec. 31, 2023 | USD 10.86 | 4.76% |
|
Italy |
|
5 |
USD -569.53 K
|
Dec. 31, 2023 | USD 53.58 | -1.47% |
|
Italy |
|
6 |
USD -987.13 K
|
Dec. 31, 2023 | USD 1.99 | -0.79% |
|
Italy |
|
7 |
USD -4.61 M
|
Dec. 31, 2023 | USD 19.14 | -0.29% |
|
Italy |
|
8 |
USD -186.44 M
|
Dec. 31, 2023 | USD 61.85 | 0.84% |
|
Italy |
|
9 |
USD -260.44 M
|
Dec. 31, 2023 | USD 107.00 | 0.25% |
|
Italy |
The Healthcare company in Italy with the highest Net Cash Used Provided By Financing Activities is Stevanato Group S.p.A. (NYSE: STVN) at USD 174.43 M.
The Healthcare company in Italy with the lowest Net Cash Used Provided By Financing Activities is DiaSorin S.p.A. (Milan Stock Exchange: DIA.MI) at USD -260.44 M.
The top 10 Healthcare companies in Italy by Net Cash Used Provided By Financing Activities are Stevanato Group S.p.A., GPI S.p.A., Genenta Science S.p.A., Newron Pharmaceuticals S.p.A., Pharmanutra S.p.A., Arterra Bioscience, Philogen S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A. and DiaSorin S.p.A..
The bottom 10 Healthcare companies in Italy by Net Cash Used Provided By Financing Activities are DiaSorin S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A., Philogen S.p.A., Arterra Bioscience, Pharmanutra S.p.A., Newron Pharmaceuticals S.p.A., Genenta Science S.p.A., GPI S.p.A. and Stevanato Group S.p.A..